Bioventus BVS Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's other accrued liabilities?
- Bioventus (BVS) reported other accrued liabilities of $15.93M in Q1 2026.
- How has Bioventus's other accrued liabilities changed year-over-year?
- Bioventus's other accrued liabilities increased by 16.3% year-over-year, from $13.7M to $15.93M.
- What is the long-term trend for Bioventus's other accrued liabilities?
- Over 5 years (2020 to 2025), Bioventus's other accrued liabilities has grown at a -4.3% compound annual growth rate (CAGR), from $21.03M to $16.85M.